190 N. Independence Mall West, Philadelphia, PA 19106.
Ann Intern Med. 2013 Oct 1;159(7):471-83. doi: 10.7326/0003-4819-159-7-201310010-00704.
The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of obstructive sleep apnea (OSA) in adults.
This guideline is based on published literature from 1966 to September 2010 that was identified by using MEDLINE, the Cochrane Central Register of Controlled Trials, and the Cochrane Database of Systematic Reviews. A supplemental MEDLINE search identified additional articles through October 2012. Searches were limited to English-language publications. The clinical outcomes evaluated for this guideline included cardiovascular disease (such as heart failure, hypertension, stroke, and myocardial infarction), type 2 diabetes, death, sleep study measures (such as the Apnea-Hypopnea Index), measures of cardiovascular status (such as blood pressure), measures of diabetes status (such as hemoglobin A1c levels), and quality of life. This guideline grades the evidence and recommendations using ACP's clinical practice guidelines grading system.
RECOMMENDATION 1: ACP recommends that all overweight and obese patients diagnosed with OSA should be encouraged to lose weight. (Grade: strong recommendation; low-quality evidence)
RECOMMENDATION 2: ACP recommends continuous positive airway pressure treatment as initial therapy for patients diagnosed with OSA. (Grade: strong recommendation; moderate-quality evidence)
RECOMMENDATION 3: ACP recommends mandibular advancement devices as an alternative therapy to continuous positive airway pressure treatment for patients diagnosed with OSA who prefer mandibular advancement devices or for those with adverse effects associated with continuous positive airway pressure treatment. (Grade: weak recommendation; low-quality evidence).
美国医师学院(ACP)制定本指南,旨在阐述成人阻塞性睡眠呼吸暂停(OSA)管理的相关证据并提供临床推荐意见。
本指南基于截至 2010 年 9 月的文献,检索来源包括 MEDLINE、Cochrane 对照试验中心注册库和 Cochrane 系统评价数据库。此外,通过对 2012 年 10 月之前的 MEDLINE 进行补充检索,发现了更多的相关文献。检索限定为英文文献。本指南评价的临床结局包括心血管疾病(如心力衰竭、高血压、卒中和心肌梗死)、2 型糖尿病、死亡、睡眠研究指标(如呼吸暂停-低通气指数)、心血管状态指标(如血压)、糖尿病状态指标(如血红蛋白 A1c 水平)和生活质量。本指南使用 ACP 临床实践指南分级系统对证据和推荐意见进行分级。
推荐意见 1:ACP 建议所有超重和肥胖的 OSA 患者都应接受减重鼓励。(推荐等级:强烈推荐;低质量证据)
推荐意见 2:ACP 建议将持续气道正压通气治疗作为 OSA 患者的初始治疗方法。(推荐等级:强烈推荐;中质量证据)
推荐意见 3:ACP 建议将下颌前伸装置作为 OSA 患者的替代治疗方法,用于对持续气道正压通气治疗有偏好或存在相关不良反应的患者。(推荐等级:弱推荐;低质量证据)